Lifecore Biomedical LFCR 深 滬
等待開盤 11-04 09:30:00 美东时间
6.42
+0.030
+0.47%
華盛通- 最 高6.44
- 今 開6.41
- 成交量 29.79万股
- 最 低 6.405
- 昨 收 6.39
- 總市值 2.43亿
- 52周最高 8.9799
- 市盈率 靜 --
- 換手率 0.79%
- 52周最低 3.625
- 委 比 -83.65%
- 總股本 3790.58万
- 歷史最高 15.96
- 量 比 0.52
- 振 幅 0.55%
- 歷史最低 1.52
- 每 手 1
- 風險率 1.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lifecore Biomedical Q2 2026 Earnings Call Transcript
Lifecore Biomedical (NASDAQ:LFCR) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. View the webcast at https...
10-08 16:17
Lifecore Biomedical to Participate at Upcoming Industry Conferences
Lifecore Biomedical, a fully integrated CDMO specializing in injectable pharmaceuticals, announced its participation in three upcoming industry events: CDMO Live Americas (Boston, Oct 19-21), Partnership Opportunities in Drug Development (PODD) (Boston, Oct 29-30), and American Pharma Manufacturing & Outsourcing Summit (Boston, Nov 20-23). At these conferences, Lifecore leaders will discuss process development and manufacturing services. Ryan Swa...
10-07 20:05
Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
10-06 10:40
Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankruptcy
New On The Block Hyperscale Data, Inc. (NYSE:GPUS), an artificial intelligence data center company, is holding discussions regarding a sale of its askROI, Inc. subsidiary and its AI business. Updates From The Block Valley National Bancorp (NASDAQ:VLY) will acquire Bluevine Inc., a leading nationwide...
10-03 01:35
William Blair Downgrades Lifecore Biomedical to Market Perform
William Blair analyst Max Smock downgrades Lifecore Biomedical (NASDAQ:LFCR) from Outperform to Market Perform.
09-29 02:23
LFCR SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES LIFECORE BIOMEDICAL, INC.
Lifecore shareholders will receive just $6.28 per share in a transaction valued at up to $663.7 million; Ademi LLP is investigating the deal price, benefits to company insiders, and restrict...
09-29 00:25
Lifecore Biomedical to Go Private in Webster Buyout
Lifecore Biomedical ( ($LFCR) ) just unveiled an update. On September 27–28, 20...
09-28 21:25
Lifecore Biomedical Q2 EPS $(0.19) Beats $(0.22) Estimate, Sales $34.200M Beat $32.016M Estimate
Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 24 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $34.200 milli...
08-05 19:18
Lifecore Biomedical Affirms FY2026 Sales Guidance of $120.000M-$125.000M vs $122.176M Est
Lifecore Biomedical (NASDAQ:LFCR) affirms FY2026 sales outlook from $120.000 million-$125.000 million to $120.000 million-$125.000 million vs $122.176 million estimate.
08-05 19:06
Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
Lifecore Biomedical, Inc. (NASDAQ: LFCR) will report its second-quarter 2026 financial results on August 5, 2026, before market open. A webcast discussing the results will be held at 8:00 a.m. Eastern Time on the same day. The webcast can be accessed live or archived for 30 days at https://ir.lifecore.com/events-presentations. Lifecore is a leading CDMO specializing in sterile injectable pharmaceuticals and has over 40 years of expertise in hyalu...
07-29 20:05
